No abstract available
Publication types
-
Consensus Development Conference
-
Practice Guideline
MeSH terms
-
Adult
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Decision Trees
-
Drug Administration Schedule
-
Fever / chemically induced
-
Fever / drug therapy*
-
Fever / prevention & control
-
Filgrastim
-
Granulocyte Colony-Stimulating Factor / administration & dosage
-
Granulocyte Colony-Stimulating Factor / adverse effects
-
Granulocyte Colony-Stimulating Factor / therapeutic use*
-
Granulocyte-Macrophage Colony-Stimulating Factor / administration & dosage
-
Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects
-
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
-
Humans
-
Neutropenia / chemically induced
-
Neutropenia / drug therapy*
-
Neutropenia / prevention & control
-
Patient Selection
-
Polyethylene Glycols
-
Recombinant Proteins
-
Risk Assessment
-
United States
Substances
-
Antineoplastic Agents
-
Recombinant Proteins
-
Granulocyte Colony-Stimulating Factor
-
pegfilgrastim
-
Polyethylene Glycols
-
sargramostim
-
Granulocyte-Macrophage Colony-Stimulating Factor
-
Filgrastim